Actively Recruiting

Phase Not Applicable
Age: 1Month +
All Genders
Healthy Volunteers
ID06841575

Advancing Pediatric Retinal Imaging With Auto-aligned OCT

Led by Duke University · Updated on 2026-03-25

50

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

Sponsors

D

Duke University

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a new handheld optical coherence tomography (OCT) device designed to automatically align with the eye to capture detailed retinal images. This pilot study aims to assess this advanced imaging technology in healthy adult volunteers, adult patients, and pediatric patients with eye and retinal diseases, addressing current challenges in imaging uncooperative patients, especially children. The study is observational and led by Duke University, focusing on improving imaging speed, alignment, and data quality for retinal assessment. The study uses a Swept Source OCT system with enhanced hand-held probe technology that auto-aligns to the patient’s eye and detects image quality in real time, automatically saving optimal images. Participants include 20 healthy adults, 20 adult patients, and 10 pediatric patients from ophthalmology clinics. Imaging will be performed during clinical visits, with up to four single imaging sessions over two years to capture detailed retinal structure and blood flow. Participants will undergo retinal imaging using the handheld OCT device during their clinical visits. Researchers will analyze images for retinal microanatomy abnormalities and retinal thickness at specific eye regions, collecting data securely for further analysis. The study will monitor outcomes over multiple sessions for up to two years, with no known risks reported from prior handheld OCT use. The total participation duration depends on the number of imaging sessions completed within the study timeframe.

CONDITIONS

Brief Title

Advancing Pediatric Retinal Imaging With Auto-aligned OCT

Who Can Participate

Age: 1Month +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy adult volunteers able and willing to consent, aged more than 18 years without known eye issues except refractive error
  • Adult patients in ophthalmology clinics able and willing to consent, aged more than 18 years
  • Pediatric patients under 18 years in ophthalmology clinics or undergoing clinically indicated anesthesia exams, with parent or guardian able and willing to consent
  • Health care provider agrees that study personnel can contact the subject or parent/legal guardian
Not Eligible

You will not qualify if you...

  • Students or employees under direct supervision of the investigators
  • Subjects with prior problems with pupil dilation
  • Pregnant women if receiving pupil-dilating drops
  • Adult patients with health or eye conditions preventing eye examination or retinal imaging, such as corneal opacity or cataract
  • Pediatric participants whose parent or guardian is unwilling or unable to provide consent
  • Pediatric patients with health or eye conditions preventing eye examination or retinal imaging, such as corneal opacity or cataract

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Up to 2 years

Participants undergo retinal imaging using a handheld OCT device with auto-alignment technology during clinical visits.

Up to 4 imaging sessions at clinical visits over 2 years

Trial Site Locations

Total: 1 location

1

Duke University Eye Center

Durham, North Carolina, United States, 27710

Actively Recruiting

Loading map...

Research Team

X

Xi Chen, MD, PhD

M

Michelle N McCall, MCAPM, BA

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

3

Similar Trials

Randomized, Double-blind Study Comparing Ranibizumab 10mg/ml...

Diabetic Macular Edema

Actively Recruiting

1 location

ICVP - A Phase I Clinical Trial to Determine the Feasibility...

Ocular Injury

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here